
The latest update is out from Lyra Therapeutics ( ($LYRA) ). On April 13, 2026, Lyra Therapeutics, Inc. agreed with RVAC Medicines (US), Inc. to terminate its sublease for about
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics | 0.03 | -3.10 | -99.04% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.03 | -99.04% |

The latest update is out from Lyra Therapeutics ( ($LYRA) ). On April 13, 2026, Lyra Therapeutics, Inc. agreed with RVAC Medicines (US), Inc. to terminate its sublease for about

Lyra Therapeutics (LYRA) announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission on Monday, April 20, 2026, to remove its

An announcement from Lyra Therapeutics ( ($LYRA) ) is now available. On March 31, 2026, Lyra Therapeutics, Inc. agreed to terminate its lease for 22,343 rentable square feet at 480

Lyra Therapeutics ( ($LYRA) ) just unveiled an update. On March 13, 2026, Lyra Therapeutics, Inc. disclosed that it received confirmation from Nasdaq that the company has withdrawn its appeal

Lyra Therapeutics, Inc. (LYRA) is scheduled to report 4th quarter earnings on 03/11/2026. Regarding Q4 estimates, Wall Street analysts expect Lyra Therapeutics, Inc. to post earnings of -$2.59 per share.

Lyra Therapeutics ( ($LYRA) ) has issued an announcement. On February 2, 2026, Lyra Therapeutics disclosed that it had received a Staff Determination Letter from Nasdaq stating that the exchange

On February 2, Lyra Therapeutics (LYRA) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market notifying the company that Nasdaq has determined to delist the company’s

New option listings for January 20th include Telefonica S.A. (TELFY). Option delistings effective January 20th include MSCI USA Gross Total Return USD Index (.MXUSA), MSCI World Net Total Return USD

Traders will find the latest deals, analyst coverage, and economic data in the Monday wrap-up.

Lyra Therapeutics stock was down on Monday after the company revealed a pause to its operations.
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.